Continued Pressure for Alveolar Protection (CPAP Trial)
NCT: NCT07417111 · RECRUITING
NCT IDNCT07417111
StatusRECRUITING
Start Date2026-11-05
Completion2029-01-30
SponsorNICHD Neonatal Research Network (NETWORK)
First posted
Last updated
Brief Summary
The objective of the CPAP Trial is to test whether extending CPAP until 34 weeks' PMA or for at least 2 additional weeks compared to weaning to a nasal canula will decrease the likelihood of bronchopulmonary dysplasia or death at 36 weeks' PMA.
Frequently Asked Questions
What is Continued Pressure for Alveolar Protection (CPAP Trial)?
Continued Pressure for Alveolar Protection (CPAP Trial) is a clinical trial registered under NCT07417111. Current status: RECRUITING.
What is the status of NCT07417111?
The current status of NCT07417111 (Continued Pressure for Alveolar Protection (CPAP Trial)) is: RECRUITING.
When did Continued Pressure for Alveolar Protection (CPAP Trial) start?
Continued Pressure for Alveolar Protection (CPAP Trial) started on 2026-11-05.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.